Select Page

Therapy Initiation Resources

  • Measures
    • Measure 114 – NK1 Receptor Antagonist (aprepitant, fosaprepitant, netupitant) or Olanzapine administered for low or moderate emetic risk Cycle 1 chemotherapy (Lower Score – Better)
    • Measure 115 – NK1 Receptor Antagonist and Olanzapine prescribed or administered with high emetic risk chemotherapy

Olanzapine Fact Sheet

TRANSLATE »